Transforming the prostatic tumor microenvironment with oncolytic virotherapy

Prostate cancer (PCa) was estimated to have the second highest global incidence rate for male non-skin tumors and is the fifth most deadly in men thus mandating the need for novel treatment options. MG1-Maraba is a potent and versatile oncolytic virus capable of lethally infecting a variety of prost...

Full description

Bibliographic Details
Main Authors: Matthew J. Atherton, Kyle B. Stephenson, Fanny Tzelepis, David Bakhshinyan, Jake K. Nikota, Hwan Hee Son, Anna Jirovec, Charles Lefebvre, Anna Dvorkin-Gheva, Ali A. Ashkar, Yonghong Wan, David F. Stojdl, Eric C. Belanger, Rodney H. Breau, John C. Bell, Fred Saad, Sheila K. Singh, Jean-Simone Diallo, Brian D. Lichty
Format: Article
Language:English
Published: Taylor & Francis Group 2018-07-01
Series:OncoImmunology
Subjects:
Online Access:http://dx.doi.org/10.1080/2162402X.2018.1445459